BioCentury
ARTICLE | Company News

EC approves GSK's Incruse for COPD

April 29, 2014 12:30 AM UTC

The European Commission approved an MAA for Incruse umeclidinium from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) as a once-daily, maintenance bronchodilator to relieve symptoms in adults with chronic obs...